Drug profile · INN
lorcaserin hydrochloride
LORCASERIN HYDROCHLORIDE
lorcaserin hydrochloride (LORCASERIN HYDROCHLORIDE) is a serotonin 2c (5-ht2c) receptor agonist. Route of administration: oral. Current US regulatory status: approved.
Drug details — lorcaserin hydrochloride
- US status
- approved
- Class
- —
- Route
- ORAL
- Patents
- 0
- Programs
- 5
- Data quality
- 0.84
Quick answer
lorcaserin hydrochloride (LORCASERIN HYDROCHLORIDE) is a serotonin 2c (5-ht2c) receptor agonist. Route of administration: oral. Current US regulatory status: approved.
Key facts
Mechanism of action
Serotonin 2c (5-HT2c) receptor agonist
Primary target: 5-hydroxytryptamine receptor 2C
Approval history
| Authority | Status | Date |
|---|---|---|
| FDA | approved | — |
Pipeline programs
Frequently asked questions
What is lorcaserin hydrochloride?
lorcaserin hydrochloride (LORCASERIN HYDROCHLORIDE) is a serotonin 2c (5-ht2c) receptor agonist. Route of administration: oral. Current US regulatory status: approved.
What is the brand name for lorcaserin hydrochloride?
LORCASERIN HYDROCHLORIDE is a marketed brand name for lorcaserin hydrochloride. Check FDA Drugs@FDA for the current US label holder and prescribing information.
What is the US approval status of lorcaserin hydrochloride?
lorcaserin hydrochloride has approved status in the United States according to our Drugs@FDA-derived records. Verify on the official FDA label before clinical or commercial decisions.